GeneDx Holdings Corp. Class A Common Stock WGS
Analyst Ratings
- Consensus
- Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $80.20 (+13.0% upside)
Key Stats
- Today's Range
- $70.69 – $75.49
- 50-Day Range
- $58.96 – $105.18
- 52-Week Range
- $32.21 – $170.87
- Volume
- 858K shs
- Average Volume
- 678K shs
- Market Cap
- $2.16 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 20.88%
- Days to Cover
- 2.71
About GeneDx Holdings Corp. Class A Common Stock
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Related Stocks
Compare head-to-head: WGS vs LFST·WGS vs PRVA·WGS vs USPH·WGS vs OMDA
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.